共 8 条
- [4] Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact?[J] . Yutao Guo,Ron Pisters,Stavros Apostolakis,Andrew D. Blann,Haijun Wang,Xiaoning Zhao,Yu Zhang,Dexian Zhang,Jingling Ma,Yutang Wang,Gregory Y.H. Lip.International Journal of Cardiology . 2012
- [6] 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J] . L. Samuel Wann,Anne B. Curtis,Kenneth A. Ellenbogen,N.A. Mark Estes,Michael D. Ezekowitz,Warren M. Jackman,Craig T. January,James E. Lowe,Richard L. Page,David J. Slotwiner,William G. Stevenson,Cynthia M. Tracy.Circulation . 2011 (10)
- [7] A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation: The Euro Heart Survey[J] . Ron Pisters,Deirdre A. Lane,Robby Nieuwlaat,Cees B. de Vos,Harry J.G.M. Crijns,Gregory Y.H. Lip.Chest . 2010 (5)
- [8] Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting:executive summary-a Consensus Document of the European Society of Cardiology Working Group on Thrombosis,endorsed by the E. Lip GY,Huber K,Andreotti F,et al. European Heart Journal . 2010